Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check20 days agoChange DetectedFooter revision label updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now shows a glossary, updates the QC label capitalization (Last Update Submitted that Met QC Criteria), standardizes the No FEAR Act notice, and adds Revision: v3.4.0, replacing the previous Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now displays a 'Last Update Posted' label, replacing the previous 'Last Update Posted (Estimated)' label.SummaryDifference0.0%

- Check42 days agoChange DetectedThe Revision label in the page footer was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check56 days agoChange DetectedA new bibliographic citation for a Phase II trial of enfortumab vedotin in gastric and esophageal cancers was added, and the prior 'Online ahead of print' citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.